Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Prevalence of Glucose Intolerance and Risk Factors in Ethiopian Immigrants in Israel; Follow-up Study.

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2011 by Hillel Yaffe Medical Center.
Recruitment status was:  Not yet recruiting
Information provided by:
Hillel Yaffe Medical Center Identifier:
First received: July 24, 2011
Last updated: July 25, 2011
Last verified: June 2011
High risk population: Screening for impaired glucose tolerance.

Diabetes Mellitus
Glucose Intolerance

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Further study details as provided by Hillel Yaffe Medical Center:

Primary Outcome Measures:
  • Percent of patients with Diabetes Mellitus or impaired glucose tolerance [ Time Frame: Day 1 of study ]

Secondary Outcome Measures:
  • Prevalence of hypertension and hyperlipidemia [ Time Frame: Day 1 of study ]

Estimated Enrollment: 550
Study Start Date: September 2011
Ethiopians participating in previous study, year 2000


Ages Eligible for Study:   25 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Ethiopian immigrants to Israel living in Hadera.

Inclusion Criteria:

  • Participation in the year 2000 study
  • Signature of Informed Consent Form

Exclusion Criteria:


  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01402362

Contact: Anat Jaffe, MD PhD +97246304748

Diabetes and Endocrinology Unit, Hillel Yaffe MC, POB169 Not yet recruiting
Hadera, Israel, 38100
Contact: Anat Jaffe, MD PhD    +97246304748   
Sub-Investigator: Liana Tripto, MD         
Principal Investigator: Anat Jaffe, MD PhD         
Sponsors and Collaborators
Hillel Yaffe Medical Center
  More Information

Responsible Party: Diabetes and Endocrinology Unit, Hillel Yaffe Medical Center Identifier: NCT01402362     History of Changes
Other Study ID Numbers: 56-2011
Study First Received: July 24, 2011
Last Updated: July 25, 2011

Keywords provided by Hillel Yaffe Medical Center:
Diabetes Mellitus
Glucose tolerance
Included in the year 2000 study

Additional relevant MeSH terms:
Diabetes Mellitus
Glucose Intolerance
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Hyperglycemia processed this record on May 23, 2017